The ultra-short course preseasonal allergy vaccine, containing the adjuvant monophosphoryl lipid A (MPL), is effective in treating allergic symptoms; however, the efficacy in controlling asthmatics symptoms has not been fully demonstrated. We aimed at evaluating whether the ultra-short preseasonal course of immunotherapy contributes to asthma control.
Scichilone, N., Scalici, V., Arrigo, R., Bellia, V. (2013). Clinical and anti-inflammatory effects of ultra-short preseasonal vaccine to Parietaria in asthma. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 7(4), 207-215 [10.1177/1753465813476564].
Clinical and anti-inflammatory effects of ultra-short preseasonal vaccine to Parietaria in asthma
SCICHILONE, Nicola Alessandro;
2013-01-01
Abstract
The ultra-short course preseasonal allergy vaccine, containing the adjuvant monophosphoryl lipid A (MPL), is effective in treating allergic symptoms; however, the efficacy in controlling asthmatics symptoms has not been fully demonstrated. We aimed at evaluating whether the ultra-short preseasonal course of immunotherapy contributes to asthma control.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Scichilone_TAR_13.pdf
accesso aperto
Descrizione: articolo principale
Tipologia:
Pre-print
Dimensione
620.86 kB
Formato
Adobe PDF
|
620.86 kB | Adobe PDF | Visualizza/Apri |
|
10447_98964.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
208.57 kB
Formato
Adobe PDF
|
208.57 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
